干细胞之家 - 中国干细胞行业门户第一站

 

 

搜索
朗日生物

免疫细胞治疗专区

欢迎关注干细胞微信公众号

  
查看: 40391|回复: 0
go

干细胞移植常用生物学词汇 [复制链接]

Rank: 1

积分
威望
3  
包包
20  
楼主
发表于 2008-12-27 14:20 |只看该作者 |正序浏览 |打印
2,3-DPG:2,3-diphosphatidylglyceric acid,2,3-二磷酸甘油酸7 t8 G$ M6 h. t* J2 k
2-CdA:2-chlorodeoxyadenosin,cladribine,2-氯去氧腺苷
# O9 M* u8 n# i3H-TdR:tritiated thymide,氚标记胸腺嘧啶核苷6 C4 G# ~& }  Z9 Z* Q: B
5-Aza:5-azacytidine,5-氮(杂)胞苷
! r( I6 ?+ N) y0 e" m  ga2-PI:a2-antiplasmin, a2-纤溶酶原抑制物' u; f* H; r+ a* G9 g
AA:aplastic anemia,再生障碍性贫血3 H$ |: U7 n+ e  Y2 J1 t
AAV:adeno-associated virus,腺病毒相关病毒1 c. D& c! S- t- L/ D( _1 X: Z
Ab:antibody,抗体- k, T1 w5 g: O  U  h% ?6 V
ABC:avidin-biiotin complex method, 亲和素生物素复合物法
; ]1 k  `+ ^9 V' d: [$ z0 ]ABMT:autologous bone marrow transplant,自体骨髓移植
6 b2 t% q2 t& P% f/ I4 AAc:accessory cell,辅佐细胞
* \  o; v! I% TACD:acid citrate dextrose,酸性枸橼酸盐葡萄糖
; a: ?4 b1 Q1 n) Z0 n  ?& A' OACP:acid phosphatase,酸性磷酸梅% f' U' F0 {9 J; D7 n; g
ACTD:actinomycin D,放线菌素D
) a5 c; n$ a  N1 r' ?! u: G4 r' \Acute:急性的 - [( l2 y* I8 z# A7 _' D
ACV:cyclovir,阿昔洛韦
9 R* Z* ^' u  z3 Q7 p" l. L6 G- }0 A. LAd:adenovirus,腺病毒  v& ~, O8 g) x* q& L
AD:antigen determinant,抗原决定簇5 w/ N3 M  X% o+ p2 X/ X
ADA:adenosine deaminase,腺苷脱氨酶7 l, H' O$ t/ @& o  L
ADCC:antibody-dependent cell-mediated cytotoxicity)抗体依赖细胞介导性细胞毒性: R4 p: X4 s6 a
Adjuvant therapy:辅助治疗
0 n, y9 n4 O" M, U( BAEL:acute erythrocytic leukemia,急性红白血病% P0 z& v1 `7 o) [; l, O
AEoL:acute eosinophilic leukemia,急性嗜酸粒细胞白血病
/ S8 K8 m( B7 |" a* tAFP:alpha fetoprotein,甲胎蛋白- h. K$ a' Z; r+ J. _3 M6 y$ ], U! q
Ag:antigen,抗原5 s" k0 i( h1 f' v- B" p
aGVHD:acute graft versus host disease,急性移植物抗宿主病) p! a7 N' {! V. s5 v* f% w0 u
Aid:anti-idiotype antibody,抗独特型抗体
1 L3 p# }/ N6 Y: |$ n9 T% w' }AidS:acquired immune deficiency syndrome,获得性免疫缺陷综合征: L* @0 ?8 G+ F, }- M
AIF:apoptosis-inducing factor,凋亡诱导因子
% ^1 C. q& ?; P8 B  g/ C* hAIHA:autoimmune hemolytic anemia,自身免疫性溶血性贫血
1 b. g& Y, T( }7 p$ m( SAL:acute leukemia, 急性白血病7 z" z+ [2 |& b7 {) w
ALCL:anaplastic large cell lymphoma,退行性大细胞淋巴瘤6 F1 X6 ]6 D6 j0 ~- e
ALG:antilymphocyte globulin, 抗淋巴细胞球蛋白
: x# ?  \% {6 S9 Z- C% ~# iALIP:abnormal localization of immature precursor,未成熟前体细胞异常定位+ h! i7 ~( n# W6 J' s, ]4 Q
ALL:acute lymphocytic leukemia,急性淋巴细胞白血病
5 @' x3 T6 E0 t5 M6 G! }Allo-BMT:allogeneic bone marrow transplantation,异基因骨髓移植7 Z5 q2 F2 B* \
Allo-PBSCT:allogeneic peripheral blood stem cell transplantation,异基因外周血干细胞移植
1 k, c/ m8 q8 o" Y' _2 rAllogeneic:异基因的 , g" R8 z% O7 `- o% j9 z$ l
Allograft:异体移植物 ) O- |1 H, y- c2 s/ ~
Alopecia:脱发- ~1 g* n; ]2 _5 \% @
ALP(AKP):Alkaline phosphatase,碱性磷酸酶
6 b) g* \- H6 z& s6 LAM:adhesion molecule,粘附分子
" T; {  X) J# @7 B1 G" ^AMKL:acute megakaryoblastic leukemia,急性巨核细胞白血病; t7 p) C; J1 s9 g- }$ H/ i* |
AML:acute myeloid leukemia,急性髓性白血病+ e+ r; ~& y6 v8 D
AMM:agnogenic myeloid metaplasia,特发性髓外化生; X' N" v8 r! B
ANA:antinuclear antibody,抗核抗体
4 I2 b$ Y0 m6 \& h/ i3 IAna-LL:anaplastic large cell lymphoma,大细胞淋巴瘤
% h- ^3 X# [, h7 |2 q2 dAnaphylaxis:过敏症
! v8 z6 R& \* T" D2 O% P( ~' l/ T) r( q3 e% h" e
ANC:absolute neutrophil count,中性粒细胞绝对值
! r, Y: [& `8 U2 ~8 ^! N# C8 |2 }8 [: hAnemia:贫血8 N/ ^- D2 I3 L, ?2 f$ G# L
ANLL:acute non-lymphocytic leukemia,急性非淋巴细胞性白血病
% h9 O* n; l: X3 k2 |+ Q# u! iAntibiotic:抗生素;抗生的
5 j( I8 r* e7 z8 S' w! T# p9 E' `Antiemetic:止吐剂,止吐药
% r% |% `6 r  \$ \3 J- {: @# Nantineoplastic drugs:抗肿瘤药物7 m$ Q8 M9 O7 J
Antisense:反义引物
# j* d2 K& L; P7 EAPBSCT:autologous peripheral blood stem cell transplantation,自体外周血干细胞移植2 B  f+ d2 o! F* ~( E
APC:antigen processing cell,抗原呈递细胞) X8 d* x5 v# t& E* Q
Apheresis:血浆分离置换法,血液成分部分清除 3 s% F5 m0 B5 }
APL:acute promyelocytic leukemia,急性早幼粒细胞白血病
- U) Z8 l" k5 `+ O9 m: m4 n) `! wAplasia:发育不良,成形不完全
. L1 j! c4 j' q' {! z/ yApoptosis:凋亡7 p; X( n" F* t4 W
Ara-C:arabinosyl cytosine,aracytidine阿糖胞苷
* K. V5 v( k/ _ARDS:acute respiratory distress syndrome,急性呼吸窘迫综合症;AidS-related diseases艾滋病相关疾病& W" \# o; Z  z
Ascites:腹水 4 y( D, W. a% ^' M3 C2 {/ D
ASCT:autologous stem cell transplantation,自体干细胞移植
9 d2 O! v& `% w0 hAspergillus:曲霉属; g# C# t5 \  {* ~- Y9 K* c; m
ASS:anterior superior spine,髂前上棘
' ^7 v4 h4 e" j! c) LAT1257:nitrocaphane,消瘤芥. h6 P6 \( h; {- e9 i
ATG:antithymocyte globulin,抗胸腺细胞球蛋白
2 j/ e, v+ C" U. s1 f/ S! v4 ^3 ?ATL:adult T cell leukemia/lymphoma,成人T细胞白血病/淋巴瘤
  w3 d( a& v0 T' ]ATLS:acute tumor lysis syndrome,急性肿瘤溶解综合征
, L8 ]5 k5 B  `( c( b. rATRA:all-transretinoic acid,全反式维甲酸5 |! l, D9 L; Q7 _* u2 d
AUL:acute undifferentiated cell leukemia,急性未分化细胞白血病
! ^5 C. y9 O0 t/ f/ `6 I6 v/ J. hAuSCT: autologous stem cell transplantation,自体造血干细胞移植  D7 k: J& {0 j$ j! y6 U
Autologous:自体的 0 A7 P7 ]) F3 e8 ?+ c
Autograft:自体移植物
& w2 u/ _6 k: a: F/ @Auto-BMT: autologous bone marrow transplantation,自体骨髓移植
5 v7 h, j! e; J" r" Jβ2-MG:β2-microglobulin,β2-微球蛋白0 H9 I1 ~5 G7 m/ i
Back-up:备份, T8 D) m# O, V1 z% z$ m' A8 x: ?
BCNU:Carmustine,卡氮芥,卡莫司汀
0 ~9 M( u; g' I* H$ a, c; NBCR:breakpoint cluster region,断裂点丛集区! y1 H* B% M  T( z7 g( z% G
BFU-E: burst-forming unit-erythroid,早期红系集落生成细胞
  u! D# u9 i4 F2 d7 Q0 a8 F0 A, BBiopsy:活检
  ]5 K9 P. i3 J6 eBlast cell:原始血细胞,母细胞 5 {2 Y/ T8 _$ W- n
Blast-CFC:blast colony forming cell,原始细胞集落形成细胞& R. x! O, k6 h4 Y& v0 s0 x
Blast crisis:原始细胞危象 0 ]7 y5 x- q; _
Bm:memory B lymphocyte,记忆B淋巴细胞
9 a5 g; V* U3 d7 g$ z' R0 |8 GBMG:benign monoclonal gammopathies,良性单克隆丙球蛋白病
, s7 A7 B: i5 SBMT:bone marrow transplantation,骨髓移植
  I, K7 B8 p( f+ ~/ R% G, EBone marrow biopsy:骨髓活检
+ E' Q. H% i. ~5 g# _Bone marrow puncture:骨髓穿刺4 [/ C4 F7 e4 [- N
Bone marrow smear:骨髓穿刺涂片* f5 g9 w/ g- g! U$ b
BRM:biological response modifier,生物应答调节剂5 f! q7 N* W3 e/ m
Bu:busulfan,白消安,马利兰
3 g! Q; z$ ^; `Buffer:缓冲,缓冲剂,缓冲液% {  T9 X% B: Q
CALLA:common acute lymphocytic leukemia antigen,普通急性淋巴细胞白血病抗原7 g' j# r  v, ]+ P5 l0 r5 K
CAM:cell adhesion molecule,细胞粘附分子
5 _: d& i/ {. }: y* m) a2 MCandida:念珠菌属,假丝酵母属 9 ^5 ]7 u( g; c' t4 \% _
Catheter:导管 4 Z9 |0 F9 p, O: [  N
CB:cord blood,脐带血( g5 c. G3 {2 O" X3 S! \( o3 ?
CB1348:chlorambucil:苯丁酸氮芥
0 f& s# J3 @0 P7 qCBC:complete blood count,全血细胞计数
$ [- J% d6 U! Z8 t5 D, jCBCL:cutaneous B-cell lymphoma,皮肤B细胞淋巴瘤
3 y" X$ y# d: Y) |7 c0 lCBSCT:cord blood stem cell transplantation,脐血干细胞移植
2 p1 V6 |' f5 e% o" ICCI:corrected count increment,校正增值计数
$ U2 P( ]: j& u+ _9 y% LCCNSA:cell cycle non-specific agents,细胞周期非特异性药物
( G8 J% p5 r1 [) j; H: F( N$ v, {CCNU:lomustine,洛莫司汀,环己亚硝脲- G8 a& E4 N/ t- g- c$ G
CCR:continuous complete remission,持续完全缓解
0 w9 }8 s, @. c; m. F* T" KCCSA:cell cycle specific agents,细胞周期特异性药物
& W* U& Z6 m. t( sCD:Castleman's disease,Castleman病9 H0 X5 b- W- D. U
CD:cluster of differentiation,分化群
' S! e1 [* p( f! G: fCD3AK:CD3 activated killer,CD3激活的杀伤细胞
% Y, d  E$ q/ a3 |: Y( BCDK:cyclin dependent protein kinase,周期素依赖蛋白激酶
. Q1 @3 g+ C8 p4 o' @& wCEA:carcinoembryonic antigen,癌胚抗原: x! s. |5 ?: a- u
CEL:chronic eosinophil leukemia,慢性嗜酸性粒细胞白血病
. v/ u! |& P  S2 Y# K; ICentral line:中心静脉导管,见central venous catheter. 3 x' T5 ]5 ~* L8 _
Central venous catheter: 中心静脉导管,又叫做central line,Hickman catheter ) I+ D* N) @2 F
Centrifugation:离心, q* Y2 N( z- x8 h% j1 ]6 v8 q
CFC:colony-forming cell,克隆形成细胞; `# Q+ ]) B6 r: D3 i% x
CFU:colony-forming unit,集落形成单位' m- f/ N+ ^. R
CFU-Blast:colony-forming unit-Blast,原始集落生成细胞
2 K( S6 f5 U( `! R+ TCFU-E:colony-forming unit-erythroid,红系集落生成细胞
& W7 B& _9 g% k2 hCFU-G:colony-forming unit-granulocyte,粒系集落生成细胞. c8 h+ y' A- g% C8 g/ q8 C9 \# [$ N
CFU-GM:colony-forming unit-granulocyte/macrophage,粒单系集落生成细胞  [; Z) ], K" q8 c$ b
CFU-L:colony-forming unit-leukemia,白血病细胞集落生成单位
1 s1 E! j6 k/ g* ?3 XCFU-MEG:colony-forming unit-megakaryocyte巨核系集落生成细胞
: E3 y% M, b% r( v& R' c# ]+ v% j0 w: mCGD:chronic granulomatous disease,慢性肉芽肿病
: A+ l3 k* k1 s3 T+ a2 B5 SCGP:circulating granulocyte pool,循环粒细胞池. L/ x% N+ n$ i- v
cGVHD:chronic graft versus host disease,慢性移植物抗宿主病
2 [8 S8 H# V( R/ O0 @1 N. W. v0 NChemo-responsive:化疗敏感的 + h' ^  P7 w# K9 p) D9 |
Chemotherapy:化学疗法 7 e# m/ ~/ R( G
Chronic慢性的 5 a0 Y! o+ s9 J  l+ A( }3 ?
C.I.:continuous infusion,持续静脉点滴
2 D1 S5 y/ z( X2 w/ f" JCIK:cytokine-induced killer cells 细胞因子诱导的杀伤细胞
- u; |" [0 a% E) bCliniMACS:clinical magnetic activated cell sorting,临床级磁性活化细胞分选系统
2 \9 C8 T$ C. G5 }CLL:chronic lymphocytic leukemia,慢性淋巴细胞白血病# y/ P. @3 S& a8 v
CML:chronic myelogenous leukemia,慢性粒细胞白血病
  m, a+ B3 X% [/ MCML-AP:CML-accelerated phase,慢性粒细胞白血病加速期
" }. J* `' l; {3 x3 ]" a- g' ?* TCML-BP:CML-blastic phase,慢性粒细胞白血病急变期
0 t/ M6 I  `; G4 X+ V; Z$ A: e& b/ RCML-CP:CML-chronic phase,慢性粒细胞白血病慢性期
) e# c- n$ B( \/ {' R; o7 W* VCMML:chronic myelo-monocytic leukemia,慢性粒-单细胞白血病
2 X& e9 G+ L  ]4 x& UCMPD:chronic myeloproliferative disease,慢性骨髓增生性疾病5 Z6 h8 {& \6 a: n( e
CMV:cytomegalovirus,巨细胞病毒( T' C& m% F& Z
CNR:cytokine negative response cell,细胞因子不反应细胞) j# O. C9 x9 Q* }- w' J" h
CNS:central nervous system,中枢神经系统: w% ?4 S3 g5 i+ \$ H% B3 [
CNSL:central nervous system leukemia,中枢神经系统白血病% s# \$ R3 i1 K) K+ q
Collection: 采集
+ D& R1 |& A$ cColony stimulating factor:集落刺激因子 ) q! `/ q! h6 d  `
c-onc:cellular oncogene,细胞癌基因/ V0 Z* `8 m" ^. j
Conditioning:预处理 * w2 i6 J, a& ]3 g
Conjunctivitis:结膜炎7 s  J; d% j* O+ p+ Z- [
Convalescence:恢复,恢复期$ Q  N2 I, H% z" }8 z7 [3 j
CP:cancer procoagulant,癌性促凝物质% j5 V" ?* D3 b/ a
CPD:citrate phosphate dextrose,枸橼酸盐-磷酸盐-葡萄糖6 L) q( [: p6 w( n  @  {1 G
CPDA: citrate phosphate dextrose adenine,枸橼酸盐-磷酸盐-葡萄糖-腺嘌呤* r5 x7 K5 M. {3 C7 v  }5 Z3 j
Cpmax:peak concentration,峰浓度
4 o2 L* s6 r6 q+ g/ I8 j: \CPT:camptothecine,喜树碱
9 o; B4 q; q0 I/ |6 q9 k. I8 w- UCR:complete remission,完全缓解( ?" {* E; j8 f) Y" z3 }5 ]
CRABP:cytoplasmic retinoic acid binding protein,胞浆维甲酸结合蛋白, v0 ?( H/ z: b# ]
CRP:C reaction protein,丙反应蛋白
7 H4 ~4 B+ K3 O) PCRR:complete remission rate,完全缓解率; r8 \2 ^/ d  U" x3 J
Cryopreservation:冷冻保存,深低温保藏 0 T: [$ ~& O, C; J) p3 k' t
CSF:colony stimulating factor,集落刺激因子5 \- P+ d; p6 Z  z0 h
CSF:cerebrospinal fluid,脑脊液
5 j9 ^2 ]. ~; _2 d+ k4 mCTCL:cutaneous T cell lymphoma,皮肤T细胞淋巴瘤  z7 O& H2 V9 V) w9 U
CTCL:central T cell lymphoma,中枢T细胞淋巴瘤
5 s7 x6 E# b7 U9 v; p2 }4 oCTL:cytotoxicity T lymphocyte,细胞毒性T淋巴细胞
+ o' `3 s# w$ v! U; _Cyclin:周期素
9 m% b% k7 V, J5 n" a* p9 qCytomegalovirus:巨细胞病毒 0 \) v7 H- d8 @# k1 X
DC:dendric cell,树突细胞4 W; C0 c# K' D* i' F
D-D:D dimer,D-二聚体4 m/ q$ o7 i4 x8 M  x
Del:deletion,缺失  l8 Z( J  M, N% x) L- y6 m1 j% s0 x
Dermatitis:皮炎
2 `7 U4 ~/ f; y, |De nova AML:非继发性急性髓性白血病
; w9 I9 C1 u9 K4 f1 G+ P  oDFS:disease free survival,无病生存期
, r, {2 @/ G6 Q+ T; NDI:DNA index,DNA 指数+ @; ]* Z3 A2 I+ f8 p# J
DIC:disseminated intravascular coagulation,播散性血管内凝血' u$ n7 O5 f9 f: k& u/ F, t3 X
Dilution:稀释  |* r/ N. S& c/ ~
DL:discordant lymphoma,混杂型淋巴瘤7 s1 a2 v! V! w( v
Donor:供者
* G: p% u. I! ~- e5 vDysplasia:发育不良,发育异常 & s# ^0 e) ^: J. ^1 ?# p
EBV:Epstein-Barr virus,EB病毒0 h! L7 Z, a- S( f9 M
ECM:extracellular matrix,细胞外基质
- }; ?  V" P! S- A  G" ]$ k+ I8 o-ectomy:(后缀)(外科)切除,除去,去掉
- Z7 n" ?7 \+ A' k$ z9 cEdema:水肿
: x) P; S" y3 x/ C5 w' K% ZEGF:epithelial growth factor,表皮生长因子% H7 L$ W" z& ]& Y8 l/ q
-emia:(后缀)血液疾病
, J: }9 |( [6 {+ W/ P" ?4 s2 S1 HEncephalopathy:脑病 , `* O! C* ?* q6 F" \0 q6 X
Encode: 编码- x9 s, _+ l1 a7 J
Engraftment:移植物植入 * R1 W* O/ w2 Z& G
Enrich:富集
& j. H; R$ }6 c+ ?1 ]4 o* TEnzyme:酶
7 y( R8 G* l9 H, c( l9 U+ ?/ @' cEosinophil:嗜酸性粒细胞9 w# X9 l  A. {9 Q! m
EPO:erythropoietin,促红素,红细胞生成素
) k: H  G( K+ U: g+ W/ L4 J1 p, ]ETT:essential thrombocythemia,原发性血小板增多症2 d7 D( X( G0 M2 G" Y! _8 H( B
Ex vivo:体外 / e5 h6 U% q5 a# W# B% R1 [+ v$ d
FACS:fluorescence activated cell sorting,荧光活化细胞分选系统
/ s$ L% j! ~( T1 x: [FCM:flow cytometry,流式细胞分析技术
2 H, \! c8 I4 m1 u/ U: QFDC:follicular dendritic cells,滤泡树突状细胞
' t# u# N9 J7 U0 Q* S7 |' u) LFDGF:fibroblast derived growth factor,成纤维细胞源生长因子 ' w  x8 H: o) f
Febrile:发热的
" d+ Q: j9 z- gFFP:fresh frozen plasma,新鲜冰冻血浆
$ m: t" |3 p1 C8 G9 kFGF:fibroblast growth factor,成纤维细胞生长因子# Y! ^: p: `% i1 P! m$ ?* o  G: {
FHH:familial hemophagocytic histiocytosis,家族性嗜血组织细胞增生症& f0 j/ b5 G0 P! E5 z
FISH:fluorescence in situ hybridization,荧光原位杂交& u2 F/ E; Z1 M. A
FMF:familial Mediteranean fever,家族性地中海热6 M  s1 }# z& `
Foley catheter:弗利氏导尿管,气囊导尿管
  _- F4 N3 s/ L" ^5 UFrTBI:fractional total body irradiation,分次全身照射. `! V# u+ D' u" n4 ^- V, j
FSRC: 胎羊体内增殖的人造血干细胞2 [8 O% |; N0 C" P
Fungus:真菌 ; E* n4 Q5 k7 N6 I# }
Fungi: Fungus复数形式
3 v. j; s9 [+ O( aG6PD:glucise-6-phosphate dehydrogenase,6-磷酸葡萄糖脱氢酶0 X# |6 X! V6 ~$ j
Gastritis:胃炎 % S; K( E' Y6 u) a1 q4 I3 Z
Gastrointestinal:胃肠道的
- n3 g! E; H# V& l2 j) X- l# SG-CFC:granulocyte colony forming cells,粒细胞集落形成细胞
  l9 k5 C, S2 K" y; PG-CSF:granulocyte colony stimulating factor,粒细胞集落刺激因子
$ C1 \' v; [$ Q1 O% V7 \GCV:cytomegalovirus,巨细胞病毒* i/ s% Y6 q( L8 m% t
GCV:ganciclovir,更昔洛韦
6 _% I$ B" y( O) C( xGI:gastrointestinal,胃肠道的
# K% c( L! R. B9 f/ o: kGM-CSF:granulocyte-macrophage colony stimulating factor,粒-巨噬细胞集落刺激因子
( W5 @1 _+ W2 G: U5 RGM-CFC:granulocyte-macrophage colony forming cells,粒-巨噬细胞集落形成细胞, h; c1 \' Z( [) M% Y1 ?# u
Graft rejection:移植排斥(反应) ' A! G# D; v7 T$ Z) h. v
Graft-versus-host disease:移植物抗宿主病 2 Z6 u4 G& P* h3 P
Granulocyte:粒细胞
' a/ k6 I1 `5 l0 SGrowth factor:生长因子
$ k1 W' P7 ~0 j% `& ZGTR:granulocyte turnover rate,粒细胞转换率
6 t" K3 q$ d1 S' ?0 v# J/ ZGVHD:graft-versus-host disease,移植物抗宿主病
# I2 M( g( J* jGVHR: graft-versus-host reaction,移植物抗宿主反应- Z0 C" `  b6 H# q
GVL:graft-versus-leukemia,移植物抗白血病6 E8 x0 B" o7 B" _3 b
GVT:graft-versus-tumor,移植物抗肿瘤7 \8 o; v" a2 I/ u' z. \
Haploidentical: 半相和的
9 w) m5 Z! z2 D: W  T8 \6 FHarvest: 收集,采集
; j( K- x* V" h8 gHC:hemorrhagic cystitis,出血性膀胱炎
! {% {4 M+ `% e" h' bHCL:hairy cell leukemia,毛细胞白血病
' \% \9 t6 k( e- [HD:Hodgkin's disease,霍奇金病) }0 h: Q1 `1 y/ D  Z
HD:high dose,大剂量) @9 v  ~' q$ S2 P4 Q* k
Hematocrit:红细胞压积 ; d5 L( ^0 E4 G" o! N
Hematology:血液学
+ D! E$ G" L% h( r$ N8 wHematopoiesis:造血作用,生血作用
; B3 G; v  m/ MHematopoietic system:造血系统
2 y0 o% C7 y0 W, p& [Hemoglobin:血色素,血红蛋白 * |- _0 t) r0 T: n  O
Hemorrhage:出血 8 q8 b" D  g( z
Hemorrhagic cystitis:出血性膀胱炎 % C; V- O  ]  ]8 j
Hepat - :(前缀)肝的
% n. a6 _" A$ a* THepatitis:肝炎
8 t) x( a2 I9 f; d* Q% ?" h& vHES:hypereosinophilic syndrome,高嗜酸粒细胞综合征
: X6 V5 Z9 P0 `  N. B, W, n* ZHGF:hematopoietic growth factor,造血生长因子
: A5 _- x4 D8 o/ _# \9 YHHV:human herpus virus,人疱疹病毒
$ m. }% B- d; X+ {Hickman catheter:Hichman导管,中心静脉插管
# Z, r/ x5 M' K& y7 U2 t4 u8 rHIV:human immune deficiency virus,人免疫缺陷病毒& X- v2 v+ N( I; a; Q- w. P# d
HLA:human leukocyte antigen,人类白细胞抗原
  M( J9 ]5 w0 Z+ `+ ^+ HHLH:hemophagocytic lymphohistiocytosis,嗜血细胞性淋巴组织细胞增生症( L/ m0 G/ N/ _  B. }
HMR:histiocytic medullary reticulosis,组织细胞性髓性网状细胞增生症+ Q% a/ w" S) c# ~& `
Homogenic transplantation:同基因移植
+ d) b1 @/ |. Q% m* s0 ]Homozygote:纯合子
) Y' y$ n. c" q( bHPC:hematopoietic progenitor cell,造血祖细胞, W  b" a$ Q8 {6 \6 \& `
HPP-CFU:high proliferative potential colony-forming unit,高增殖潜能集落形成单位
/ O, C' c5 {* w1 c% `HR-ALL:high risk ALL,高危型急性淋巴细胞白血病
9 v% V  T9 T$ a5 C7 y" FHSC:Hand-Schuller-Christian disease,韩-薛-柯病2 K9 Q9 }1 t, l: k$ O; S
HSC:hematopoietic stem cell,造血干细胞
- j% Z! `# U, z5 H9 \8 OHSR:homogenously staining region,均染色区2 ]7 N0 J; `: C# \( x
HSV:herpes simplex virus,单纯疱疹病毒
/ I# J. r$ ]/ C- _9 v: o4 `: JHTC: typing cell,纯合子分型细胞$ |( E; A- h6 C5 k) E1 _2 M
HTLV:human T cell leukemia virus,人类T细胞白血病病毒
& D6 }% a1 t* i+ m! L8 c' b5 `5 VHVOD:hepatic venous occlusive disease,肝静脉闭塞病) ~. a7 I( L$ u6 s7 R. ~
Hyper- :(前缀)高,超,(过)多( M. a/ P% c$ H, i
Hyperalimentation:高营养支持,静脉高营养( W( ?) ]2 X- V2 P2 I! l) U9 T
Hyperpigmentation:色素沉着过度 & U/ w3 m& k+ A
Hypertension:高血压 ) ^1 h$ u/ R8 O$ t9 k
Hypo- :(前缀)(过)低,少于
* z- ^% E8 Q1 g# EHypotension:低血压. A% ]) H5 C0 T6 s  n. K( G% d* u1 l
IAHS: infectous-associated hemophagocytic syndrome,感染相关嗜血细胞综合征! O: M7 @( v" v# m
id:medium dose,中剂量2 v1 @, e6 x2 V; L+ @4 q
id:initial dose,初始剂量4 r8 `8 l+ w) A3 Q
IF:involved field,累及野
- }$ X+ I+ l; }) ~, U+ |IFN:interferon,干扰素
/ A$ j  e9 P& C+ Q! v5 g5 LIg:immunoglobulin,免疫球蛋白
6 ?4 i! |' }0 r/ ~3 bIGFs: insulin-like growth factor,胰岛素样生长因子
7 Z4 w  H. v1 E; v$ r, E- @) f1 ~IgH:immunoglobulin heavy chain,免疫球蛋白重链
+ x: m$ d# F7 A/ N/ yIL:interleukin,白细胞介素) |* I- O. l: j
Iliac crest:髂嵴 2 h1 }, t) Z4 d9 l, t7 c  ^1 ?
I.M.:intramuscular,肌肉注射. G- S% J' l, [' ^9 B6 \+ ~
Immune system:免疫系统 * P  g8 N4 J+ R
Immunocompromised:免疫受损的
8 k+ d# C" T3 O7 O, s. q& l9 E3 ?Immunoglobulin:免疫球蛋白
& }5 I5 B5 ^6 t" N. y/ k; pImmunological tolerance:免疫耐受
9 b+ f$ p. I' o) [# v$ j4 o) w% [  zImmunosuppression:免疫抑制
/ S- H. i+ o7 B) f( VIncubation:孵育: `. i! m; a/ G- Z4 q- v9 s3 j
informed-consent:知情同意2 q3 d( N5 u" V" F4 Q
Intravenous:静脉内的2 T5 h/ d' \5 ]1 v
inv: inversion,倒位
$ I* `! D/ |1 t5 s" e2 X$ H' D; Oin vitro: 体外,离体2 T, R% C" G1 H. l, L4 C) ?  Q$ z
in vivo: 体内
0 B2 B- M" J# O; F7 TIP:interstitial pneumonia,间质性肺炎
! g7 {3 h( D% e4 G4 ^% A3 tIsolation: 分离
0 z' B9 W- X5 u5 Q  _3 }I.T.:intrathecal injection,鞘内注射2 \9 S. F) e5 P* I  k
-itis:(后缀)炎症
8 M0 o, L( Y! ?9 ]# I) v* U$ c2 hITP:idiopathic thrombocytopenia purpura,特发性血小板减少性紫癜
" A6 a4 R6 ^$ X7 a2 i* EJaundice:黄疸  v" t/ b  K  u9 y1 R+ d  ^% W
KPS:Karnofsky score, Karnofsky评分& J9 ^5 n) r3 A2 h4 u& d& ?6 a
LAK:lymphokine-activated killer(cells),淋巴因子激活杀伤(细胞)
9 Y: U6 V, J1 `/ {: k' RLaminar air flow unit:层流间 8 x& t7 f3 A. q- H/ L2 j( t* {, O
LCH:Langerhans cell histiocytosis,郎格罕细胞(组织细胞)增生症
3 U" q$ N& \) @1 e) J6 wLD:lymphocyte depletion,淋巴细胞消减型
6 _/ z2 S" i$ ~9 ^1 eLD:low dose,小剂量' s5 i( T9 q, |* r# S! h
LDH:lactate dehydrogenase,乳酸脱氢酶
+ t9 M3 H0 ]8 t+ ]: @8 `Leukapheresis: 白细胞采集物& K" I- a; G+ N4 y
Leukemia:白血病 1 x: k. `  L# M4 K, t( f
Leukocyte:白细胞3 T0 j. `0 J! t2 l6 U2 ~
Leukopenia: 白细胞减少症
+ X# Q# P) e. _8 m2 OLFA:lymphocyte function associated antigen,淋巴细胞功能相关抗原 5 A$ a) A% N% g' n
LFS:leukemia free survival,无白血病存活期# q/ |1 i4 a2 H& V/ }6 ?" Q
LGL:low grade lymphoma,低度恶性淋巴瘤+ r& C- U0 l) K3 w
LHR:lymphocytic homing function receptor, 淋巴细胞归家功能受体
+ S# E+ L6 |( q; ~5 x1 b/ Z! rLI:labeling index,标记指数& a" P- A. h3 S- C- ?, q8 l
LIF:leukemia inhibition factor,白血病抑制因子7 W7 D# [) `' |+ U
Lineage:系
+ l0 t& d6 n, ^. X" j' p8 vLOH:loss of heterozygosity,杂合性丢失) B: a7 n% a- F! _3 y
LP:lymphocyte predominance,淋巴细胞为主型
7 G- ?' s7 W3 a& P4 XLRP:lung resistance related protein,肺抗性相关蛋白
2 O% l- c( a5 eLTB:life-threatening bleeding,致命性出血
! ^! A* l  U; \* f1 U% MLTC-IC:long-term culture-initiating cell,长期培养起始细胞( s6 h# @: t  V6 y# ]- X
LTR:long terminal repeat:长末端重复序列
# e9 v" G) L: Q4 ]) l3 BLVL:large volume leukapheresis,大容量白细胞单采
# O% p# b! ?- vLymphocyte: 淋巴细胞7 x0 g% ]9 ~* R- w$ J4 H! F
Macrophage:巨噬细胞
' u# M; ?( ?' C) sMACS:magnetic activated cell sorting,磁性活化细胞分选* T! h3 S) _3 `/ f4 W$ e
MAK: monocytokine-activated killer(cells),单核细胞因子激活杀伤(细胞)/ D5 t8 m$ Q$ C" ?5 s2 h! i9 M+ K
Malabsorption:吸收障碍
3 y8 k8 o  N* e( U7 XMALT:mucosa-associated lymphoid tissue,粘膜相关淋巴样组织÷
  `. Z6 s* k( |. k' f  I6 m# s: gMatching:配型
) k' B5 }: Z6 Q: LMBDI:marrow blast decline index骨髓原始细胞减少指数
2 Y' r8 Y2 O  {8 A, z9 \MC:mixed cellularity,混合细胞型
, w7 o" N  d3 b! E6 H% RMcAb:monoclonal antibody,单克隆抗体6 L# h3 a; K: j5 a- c8 J
mCR: median complete remission,中位完全缓解
& T# `% G2 X+ h+ q0 z6 D- NMDR:multiple drug resistance,多药耐药
3 r! ?2 w6 ?' m" z! hMDS:myelodysplastic syndrome,骨髓增生异常综合征  D, K, _/ U+ c6 w9 g3 R* ~5 x9 J
Megakaryocyte:巨核细胞; Q- [" s9 S, w. M7 M
Metabolite:代谢物 & S/ Z0 U. H( l) o3 V% T9 G1 q; h% D; ~
Metastatic:转移的 ( R2 i4 E: g4 m% i1 Y1 L
MF:myelofibrosis,骨髓纤维化
3 t1 d: t2 L: QMF:mycosis fungoides,蕈样霉菌病
4 E  c8 F. m5 x- Y  i( v8 K) j3 S7 ^7 U. zMGDS:megakaryocyte growth and differentiation factor,巨核细胞增殖分化因子
, P% I. R4 A) B9 Z& ?, b, DMGP:marginal granulocyte pool,边缘粒细胞池
0 P. g) r# z4 g# t+ U$ `  n6 ~$ |MGUS: monoclonal gammopathy of undetermined significance,未定性的单克隆γ球蛋白血症  [) e; ?! b3 c! K+ s+ _
MH:malignant histocytosis,恶性组织细胞增生症) w, }. h8 ^6 U4 E3 c/ N; y
MHAS:minor histocompatibility antigen systems,次要组织相容性抗原系统( Z) n2 x6 m+ _* ^2 f; ^
MHC:major histocompatibility complex,主要组织相容性抗原复合体# X7 M$ j; q, M: S( g- I
MLC:mixed lymphocyte culture,混合淋巴细胞培养
0 l( k. D# g2 P  @  e, n- g4 SMLL:mixed lineage leukemia,混合系白血病7 c3 `, H3 |5 v( A
MM:multiple myeloma,多发性骨髓瘤
# t* i/ s9 y& f, a# E  L" GMNC:mononuclear cells,单个核细胞% G* `: U0 h- \# d2 j8 P
Mobilization:动员
- k) ~5 x: X  X8 JMonoclonal antibody:单克隆抗体
& f5 R& x9 S2 q: GMonocyte:单核细胞 - G, \+ B6 T" B* F& ^2 a8 V$ T
Monozygotic:单合子的( n9 D  F1 _: ^) p- |( {& D& i
Morbidity:发病率 ! a! @" Q% a1 e
MPD:myeloproliferative disease, 骨髓增殖性疾病
! o( f' T% O2 @1 K7 S! n3 ~8 tMPO:myeloperoxidase,髓过氧化物酶
( {/ Q1 d6 K+ T/ K; G2 Y6 K( z6 TMRD:minimal residual disease,微小残留病变 4 ?8 I& y# B* D7 N! n. a" @) ^- H* t+ a
MRP:multidrug resistance-associated protein,多药耐药相关蛋白
# H# n' e1 j, U9 g/ S, a' @3 S* XMucositis:粘膜炎 ) P6 Z/ v) m* L6 V# ^( g
MUD:matched unrelated donor,非血缘关系配型相合供体2 B  n: d1 I6 N  M8 l* s
NAP:neutrophil alkaline phosphatase,中性粒细胞碱性磷酸酶
7 g. t; U$ b8 V* a5 uNB:neuroblastoma,神经母细胞瘤
9 o# r  @! P+ f# r% I. `( u/ J: ANBM:normal bone marrow,正常骨髓
2 R" N# W" w- g+ K6 tNegative selection:阴性选择) Q) j1 i, D3 p  F' n- m
Neuro- :(前缀)神经的
$ U+ c3 X" ~$ h. m3 jNeutropenia:中性粒细胞减少症
* U$ L) W% p( E3 [" YNeutrophil:中性粒细胞 + a) W7 w# Y  T
NG:neutrophil granulocyte,中性粒细胞* c# C' l0 t) F' D. i
NGF:nerve growth factor, 神经生长因子
! s! a9 b) {* ]6 JNHL:non-Hodgkin's lymphoma,非霍奇金淋巴瘤) y( t. ^, \9 k, @) ~$ w
NK: nature killer cell,自然杀伤细胞* i/ ~3 p8 ]; d- Q; O! w
Nonmyeloablative transplantation: 非清髓性移植/ a! L, x7 P+ o5 E& U( ?0 D$ ?
NPO:不能进食
) i9 J3 _8 P. u. a; S; H! t5 @NS:nodular sclerosis,结节硬化型
7 k0 ^( Y2 q0 m7 COncology:肿瘤学
; A$ ^% u' A3 X6 X. }% ZOto- :(前缀)耳的
: G, S# k# R4 }9 SPA:plasminogen activator,纤溶酶原激活物  d+ |: b% r% M
Packed red blood cells: 压积红细胞 * B4 Q" c  d( D8 e( G4 N
PAE:post antibiotic effects,抗生素后续作用
: O: B) i- h+ Y# M/ E! q( d+ H' l9 ^PAI:plasminogen activator inhibitor,纤溶酶原激活物抑制剂* ~1 N+ |8 e+ T' n# x, \" `
Palliative:减轻的,缓解的
/ e: u/ I: p& n% hpalliative care unit (PCU):终末期病房,临终关怀病房# |8 I3 l% K7 H# ]. _/ o3 z
Pancytopenia:全血细胞减少症   z  t' i( [) ?5 \
-pathy:(后缀)病 . z# l# z' s0 E
PB:peripheral blood, 外周血
  t1 p* r7 K5 [6 I2 QPBL:peripheral blood lymphocyte,外周血淋巴细胞# T3 ^) |. {3 _; U% J/ @" h8 A
PBPC:peripheral blood progenitor cell,外周血祖细胞; Q. j1 x2 W4 X9 }% N  @, c
PBSCT:peripheral blood stem cell transplantation,外周血干细胞移植. w: {7 `" \" u: y' b7 A2 |1 _
PCA:procoagulant activity,促凝活性物质7 ~: Y. _/ ~/ Y6 p% e/ f
PCD:programmed cell death,细胞程序化死亡9 {9 |, G9 C$ G7 O. p
PCL:plasma cell leukemia,浆细胞白血病! O: W/ A1 r' E. {5 m1 d
PCLI:plasma cell label index,浆细胞标记指数3 }% ~8 R* t. h7 k. F# c
PCR:polymerase chain reaction, 多聚酶链反应6 R' q! L1 X" J3 w" k8 d6 U* w
PCR-RFLP: PCR-restriction fragment length polymorphisms,限制性片段长度多态性分析
- y; p1 ?( H% v5 DPCR-SSOPH: PCR-sequence specific oligonucleotideprobe hybridization,序列特异性寡核苷酸探针杂交- ~9 v% A( z/ P% X( p; C
PDD:percentage depth dosage,百分深度剂量3 C/ Y& J7 q9 i9 r& F) I
PDGF:platelet derived growth factor,血小板衍生生长因子7 d7 r- Q6 o/ \( n
PDR:primary drug resistance,原药耐药, a  a2 c1 V4 J4 m7 k1 l
PE:plasma exchange,血浆置换
+ q: K; L0 W- t$ c' ?, f-penia:(后缀)缺乏,不足
6 s  V) q7 c1 K, ]Peripheral neuropathy:周围神经病变 6 l) r5 U7 |8 n1 Q0 X' i
Petechiae:瘀点,瘀斑 1 W5 }  A5 p" K
Pfu: plaque forming unit,空斑形成单位6 z9 P( Q3 _. B& _( l, j
PHA:phytahematoagglutinin,植物血凝素1 G. g( B- J+ W& X2 R! \! S
Phlebitis:静脉炎
  [- x/ D0 y, j- ~4 EPHSC:pluripotential hematopoietic stem cell,多能造血干细胞
+ }7 Z. j9 Q9 c-plasia:(后缀)发展,形成
/ ^+ t7 F- |3 @2 w. F1 _  ~7 JPlasma:血浆  \; x  ~: O0 J: m; q9 w% ^
Plasma cell: 浆细胞 ! E3 J( v* Y! U9 d4 q8 W
Platelet:血小板
! ^( Z( z  u5 I% U% _PLG:plasminogen,纤溶酶原
7 @8 r% O  l6 L. f: {PLL:prolymphocytic leukemia,幼淋巴细胞白血病: @! E( T/ M4 U2 L: a
PLT:platelet,血小板* l$ b- }0 y8 [9 A1 J" N2 ~
PLT:primed lymphocyte test,预致敏淋巴细胞试验; z8 @7 y% S3 c
PMN:polymorphonuclear leukocyte,多形核白细胞
! x) r( H& P) T, |+ K& o# v. zPNH:paroxysmal nocturnal hemoglobinuria,阵发性睡眠性血红蛋白尿÷
5 I8 p* M+ O; n/ i: l4 }PNRE:p53 negative response element,p53阴性反应元件
; _. v) O! l7 i$ yPOD:PML oncogenic domain,PML癌基因结构域6 {2 e% c- z4 ]1 H& Y! x; @1 b
Polycythemia:红细胞增多症 # p' x7 t3 q1 l- o. K; [: f/ k
Positive selection:阳性选择
: n- I; R/ j' R- p3 n% p1 p3 k1 APPSC: pluripotent hemotopoietic stem cell,全能造血干细胞
9 T  ?7 a( G* S1 I9 j7 OPreparative regimen:预处理方案 * W. t6 }# l/ s" }. {# F4 n- V
Progenitor:前体,祖先; s! `0 B4 ~. H1 g! V, p
Prognosis:预后 / p- p; _# m8 l- s+ z  L$ x2 ?( s9 u
Prophylactic:adj.预防的;n. 预防性,预防药& d# O! g$ K+ J0 }! A- X+ C: y
Prophylaxis:预防法,预防+ U- n& R! h+ o$ B3 Q; m
Protocol:草案,协议,治疗方案
! c; L9 a! q* BProto-onc: proto-oncogene,原癌基因
* R) ^7 u& X: ^9 ^% i2 w/ v0 c! r; t, CPSS:posterior superior spine,髂后上棘
( D/ G- u5 L( I7 A$ |7 |) UPT:prothrombin time,凝血酶原时间( E. E/ y' [! ]9 C! g. l
PTCL:peripheral T celll lymphoma,外周T细胞型淋巴瘤# Z6 L( [$ T  ]7 M
PTH:post-transfusion hepatitis, 输血后肝炎
  T  C( z, ~% w0 Y2 G/ |8 O* OPulmonary:肺的
& \0 l9 [, T* Z) }+ k0 jPurging:净化# W+ F/ B0 E( z9 V: U
Purity:纯度; f+ i: Z/ r+ Y
PV:polycythemia vera,真性红细胞增多症3 O* O% }( Y% n4 b/ [6 f5 w! y& K
Quality of Life (QOL):生活质量
" W  D% [8 p) t! nRA:refractory anemia,难治性贫血 , X, n5 G$ a: J
RAEB:refractory anemia with excessive blasts,难治性贫血伴原始细胞增多型0 q% e7 x# `$ g; Y2 ]
RAEB-T:refractory anemia with excessive blasts,transformation,难治性贫血伴原始细胞增多转化型" G5 T3 |1 O$ J
RAR:retinoic acid receptor,维甲酸受体
# Z" o0 K6 T$ ERAS:refractory anemia with sideroblasts,难治性贫血伴环状铁粒幼细胞增多
0 S4 `# P7 m7 E4 p; _RAS:retinoic acid syndrome,维甲酸综合征8 j9 h0 G' W: e/ L
RB:retinoblastoma,视网膜母细胞瘤
2 k: y7 O" A; w6 E' cRBC: red blood cell,红细胞 4 [" Z3 O+ b5 X# d# J* o! |
Reagent:试剂+ C/ B. r! a+ Y2 D; ~
Recipient:受者
0 m7 U* Y2 Q1 g/ y) f. R( a! ARejection:排斥4 `- b& k7 i# q
Relapse:复发
: O) Y4 W+ V/ l1 }3 S# @. v9 rRemission:缓解 2 \7 n$ v' A- f- {& t3 ]& u" M0 @% n
Renal:肾脏的,肾的
; j/ v9 ?. O( T' a6 L$ pRFS:replase free survival,无复发生存, x+ u: {9 d# R7 A
RPC:radiation protective competence, 辐射保护能力6 B& {  \/ v1 B
Regimen-related toxicity (RRT):预处理相关毒性
# S7 T( m' g( c7 vRT-PCR:reverse transcription polymerase chain reaction, 逆转录多聚酶链反应6 e7 |# K, k) p1 W0 s" f% L( h
SBB:sudan black B,苏丹黑B
$ C: W4 N" ?' x- h1 X- @& qSCE:sister chromatial exchange,姐妹染色单体交换
$ l2 `3 d% M7 mSCF:stem cell factor,干细胞因子
% R6 Z! a, ]1 I  uSCid:severe combined immunodeficiency disease,重症联合免疫缺陷
0 Q# D3 @  f! }$ _3 GSCL:stem cell leukemia,干细胞白血病
( P) t) v- K' i' RSE:specific estarase,特异性酯酶
' V' R# \, F- m' Z* }. V. }/ iSelectin:选择素+ h: e6 N# @& S* v6 U
Sense primer:同义引物' A1 b; K! ?) `3 v! o9 Q
Separation:(细胞)分选6 C; y: `3 q4 X5 z& o
Sepsis:脓血病,败血病
+ H6 V/ S$ V. f; |" n6 y& nSequencing测序
" s, u" J3 p% e% z% ~SF:serum ferritin,血清铁蛋白5 L5 D3 C" v) O$ p# \$ p
SHML:sinus histocytosis with massive lymphadenopathy,窦性组织细胞增生症伴块状淋巴结肿大/ s4 H5 `# R7 \
SIA:stroma-support immunocytometric assay,基质支持免疫细胞流式细胞仪技术法3 \4 v. R0 H8 T  [6 P5 h: z  D
SLE:systemic lupus erythematosus,系统性红斑狼疮
: o1 D# F% ~5 r% nSLL:small lymphocytic lymphoma,小淋巴细胞淋巴瘤. X2 M8 M9 L1 N. H* W: \0 s$ g
Solid tumor:实体瘤/ c  {" d/ F& q( B( _- c
SR-ALL:standard risk acute lymphocytic leukemia,标危型急性淋巴细胞白血病, i; ]; ^& j, p/ e2 G, X) D
SRC:SCid/NOD小鼠体内增殖的人造血干细胞,SCid造血重建细胞4 k0 w2 G% c; k$ k# s& i. d
SS:Sezary syndrome,Sezary综合征
) M! D9 t0 L5 o) }: F5 ^Stem cell:干细胞
  P- p; `! b# Y: r2 CSTNI:subtotal nodal irradiation,次全淋巴结照射
3 b; J; p( F4 L( k0 [: k0 cStomatitis:口炎
% `. S$ j' y) qSubclavian catheter:锁骨下导管
, H7 _( E* J; d8 cSupernatant:上清" D$ z* n$ Y8 Q. I; V2 P
Syn-BMT:Syngeneic bone marrow transplant:同基因骨髓移植
& _* c6 G4 w+ C  |4 _Syngeneic:同基因的
3 Q, J7 M" k: H9 F3 i* lTAM:tumor associated macrophage,肿瘤相关巨噬细胞
2 z) I- }% G1 k$ x: p( lt-AML:treatment associated AML,治疗相关的急性髓性白血病
0 [( \) n$ ]% @! y" b4 i2 jTA-GVHD:transfusion associated graft-versus-host disease,输血相关的移植物抗宿主病, Y9 v, \% `  z
TAA:tumor associated antigen,肿瘤相关抗原
' |/ C+ Y1 N2 y% `9 g: ~TBGP:total blood granulocyte pool,总血液粒细胞池
/ @: f$ B4 q  y7 i9 d3 V% GTBI:total body irradiation,全身照射
6 A$ F4 I6 S6 R, ^; Y% b4 b/ |" h! RTc:time of cell cycle, 细胞周期时间2 H5 G2 s: N, h0 U  j
TCD:T cell depletion, T细胞去除( l0 f( v5 D! Z) U
TCL:T cell leukemia/lymphoma,T细胞白血病/淋巴瘤
, Y! _$ a% m8 QTCR:T cell receptor,T细胞受体
1 f# y! k' |" d0 nTCS:tumor cell survival,肿瘤细胞成活: m* f  W8 i2 {( A+ X0 |, a
TEN:total enteral nutrition,完全胃肠内营养6 g; g+ n2 p& a2 }- y" B
TF:tissue factor,组织因子
( C7 I; o2 b& aTF:thymic factor,胸腺因子8 i$ N! d* b% P& t  S$ k
TFPI:tissue factor pathway inhibitor,组织因子途径抑制物
, w. B# u' {3 u( ]$ DTGF:therapeutic gain factor,治疗获得系数
; e2 `+ s8 O6 v6 B* ^2 WTGF-β:transforming growth factor-β,转化生长因子β
5 o0 Z  `- ]6 D' C& `. U) Z. yThrombocyte:血小板 1 Y: [& h' a( I9 g% h" f+ W
Thrombocytopenia:血小板减少症
+ n# Y1 X: q! D5 B; O! [TIL:tumor infiltrate lymphocyte,肿瘤浸润淋巴细胞9 E" H" B% l, u9 {) g4 o
TL:testis leukemia睾丸白血病
' l- d6 @$ A: G1 PTLI:total Lymphoid irradiation,全淋巴照射& p0 N" r& e% [: t! s4 k
Thrombotic microangiopathy (TMA):血栓性微血管病) H9 X" h" m4 O/ K& |: s7 R
TNF:tumor necrosis factor,肿瘤坏死因子7 N: {' M/ d  v3 n& U' j
TNI:total nodal irradiation,全淋巴结照射
; w7 k5 j- q& @0 C! K$ }, bTOPO II:topoisomerase II,拓扑易构酶II  {% u4 e$ m" c/ A2 ?
Toxin:毒素 0 y9 P2 ?' D3 g. ?9 f3 Z; d) o
Tpdt:potential doubling time,倍增时间) q2 d: D6 L5 Y& a9 w
T-PLL:T-prolymphocytic leukemia,T幼淋细胞白血病. w0 a; L7 e0 ~5 |" d% e$ M
TPN:total parenteral nutrition,全肠道外营养,静脉高营养: i8 c. q: r. w" D: \) t  @
TPO:thrombopoietin,促血小板生成素
" A' F3 f. B7 ?TPS:treatment planning system,治疗计划系统
; J! C% E" q8 v8 m: J, JTranslocation:易位
$ {7 |0 g# L. _8 O; ~8 D4 QTrauma:创伤 6 w  ]" W# w" d2 `
TRM:transplantation related mortality,移植相关死亡率2 g' O' i) d- C# O6 D/ C* f
TSC:timed-sequential chemotherapy,时相序贯化疗* x' ]4 r, o7 s
TSPA:triophosphoramide,噻替派
; N' K, i( D4 x/ i4 J+ O" NTTP:thrombotic thrombocytopenic purpura,血栓性血小板减少性紫癜2 p- a! S: T9 {8 o5 w( E
Tumor:肿瘤 $ f2 Y& Q" Y- |( S: m6 m: N7 X
Tumor burden:肿瘤负荷 . E/ B7 L$ G+ t4 L; |! v. n" }, |
UCB:umbilical cord blood,脐带血/ T  ^3 I7 [' E5 P# B7 t
Ultrasound:超声 # W' n9 @  O) a( t$ o' A3 L5 f; W
Umbilical cord:脐带
8 F" n8 x" m' qVAHS:viral associated hemophagocytic syndrome,病毒相关嗜血细胞综合征- ^3 c' f1 k9 L$ Z. ~1 ~0 {
VGPR:very good partial remission,非常良好的部分缓解
  F& c; D% }( F3 _  S9 KViability:活性+ h& q+ g" l1 s& M$ ^
Virus:病毒 : }2 d9 u1 e% \' X+ L
VOD:veno-occlusive disease,静脉阻塞性疾病 + u, _2 r" u- @4 S( a
v-onc: virus oncogene,病毒癌基因
2 z. @& y- M0 mVPF: vascular permeability factor,血管渗透因子4 F: l/ E0 n. E6 ?
VZV:varicella zoster virus,水痘带状疱疹病毒1 k8 ?& E+ `& o- W: \
WBC:white blood cell,白细胞 - c- J+ a( a. l% B7 {
Whole blood:全血
( s8 Y, b6 Z$ J6 sWT:Wilms tumor,肾母细胞瘤; A! E; g' G* G$ u' y
Xerostomia:口腔干燥症 ( ]' h9 t" J$ C
Yield:产量
‹ 上一主题|下一主题
你需要登录后才可以回帖 登录 | 注册
验证问答 换一个

Archiver|干细胞之家 ( 吉ICP备2021004615号-3 )

GMT+8, 2025-11-29 22:55

Powered by Discuz! X1.5

© 2001-2010 Comsenz Inc.